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Abstract 
Fibroblasts are the major cellular component of connective tissue and experience 
mechanical perturbations due to matrix remodelling and interstitial fluid movement. 
Transforming growth factor く1 (TGF-く1) can promote differentiation of fibroblasts in 
vitro to a contractile myofibroblastic phenotype characterised by the presence of g-
smooth muscle actin (g-SMA) rich stress fibres. To study the role of mechanical 
stimulation in this process, we examined the response of primary human fibroblasts 
to physiological levels of fluid movement and its influence on fibroblast differentiation 
and responses to TGF-く1. 
We report that in both oral and dermal fibroblasts, physiological levels of fluid flow 
induced widespread changes in gene expression compared to static cultures, 
including up-regulation of genes associated with TGFく signalling and endocytosis. 
TGF-く1, activin A and markers of myofibroblast differentiation including g-SMA and 
collagen IA1 were also increased by flow but surprisingly the combination of flow and 
exogenous TGF-く1 resulted in reduced differentiation. Our findings suggest this may 
result from enhanced internalisation of caveolin and TGF-く receptor II.   
These findings suggest that a) low levels of fluid flow induce myofibroblast 
differentiation and b) fluid flow antagonises the fibroblast response to pro-
differentiation signals such as TGF-く1. We propose that this may be a novel 
mechanism by which mechanical forces buffer responses to chemical signals in vivo, 
maintaining a context-specific fibroblast phenotype.  
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Introduction 
 
All living cells are constantly exposed to a number of physical forces. Repair and 
development of an organ or a tissue is governed by the integration of both physical 
forces and chemical signals (Mammoto and Ingber (2010). These physical forces 
comprise both endogenous forces such as cytoskeletal contractility and exogenous 
forces such as shear stress and interstitial fluid flow. Cells sense and respond to 
these different cues to maintain homeostasis. However, in pathological conditions 
such as fibrosis (Ban and Twigg, 2008) and cancer (Swartz and Lund, 2012) these 
adaptive mechanisms are disrupted. 
 
The microenvironments of growing tumours and healing wounds are known to be 
highly dynamic (Schultz et al., 2011, Wiig et al., 2010) but generally display 
increased mechanical stiffness (Handorf et al., 2015) due to accumulation and 
reorganisation of extracellular matrix (ECM) proteins and increased interstitial fluid 
flow (Jain et al., 2014). Fibroblasts are the main cellular component of connective 
tissue and secrete components of ECM such as collagen and matrix modifying 
proteases including matrix metalloproteases (MMPs). They can differentiate into 
myofibroblasts when stimulated by TGF-く1 and other pro-differentiation signals 
(Hinsley et al., 2012), a transition which is characterised by increased 
phosphorylation of SMAD3 (Kamato et al., 2013), enhanced expression of g-smooth 
muscle actin (g-SMA) (Honda et al., 2010), collagen IA1 and other matrix proteins 
(Pan et al., 2013).  Myofibroblasts develop g-SMA-rich stress fibres that enable them 
to contract to promote wound closure and upon completion of healing, they undergo 
apoptosis. However, in pathological conditions such as cancer where there are high 
levels of interstitial fluid flow and angiogenesis (Thannickal et al., 2004), fibroblasts 
remain activated indefinitely and this is associated with poor prognosis (Vered et al., 
2009).  
 
As most studies on TGF-く1-induced fibroblast differentiation have been pursued in a 
static culture environment, it is highly likely that TGF-く1 stimulated fibroblasts may 
show variations in their phenotype in a physiologically relevant, dynamic 
environment in which cells experience both physical forces and chemical signals. 
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The aim of this study was to investigate the response of fibroblasts to mechanical 
forces and chemical signals in a physiologically relevant dynamic environment. We 
report that fluid flow confers an „activated暢 phenotype to normal fibroblasts and this 
differentiation is reversed when flow is withdrawn, and reduced in the presence of 
exogenous TGF-く1. We reveal that increased levels of TGF-く1 and activin A may 
mediate this activation of fibroblasts by flow, and that an increase in endocytosis 
including internalisation of TGF- くRII could explain the reduced response to TGF-く1 
under flow.  Our results provide the first evidence of fluid flow mediated “tensional 
homeostasis” that buffers the fibroblast phenotype in response to pro-differentiation 




Dermal fibroblasts show variations in gene expression when subjected to fluid 
flow 
In order to identify fluid flow induced changes in gene expression profile of 
fibroblasts, we performed microarray analysis of transcript levels in dermal 
fibroblasts subjected to physiological rates of fluid flow (75 and 150 µl/min) 
(A.Ahluwalia 2011, Sbrana and Ahluwalia, 2012, Vinci et al., 2010b) using the 
experimental set up illustrated in Figure 1a.  Using this approach, we identified 2944 
transcripts differentially expressed between dermal fibroblasts in static and flow 
conditions (p<0.05) at both flow rates (75 and 150 µl/min) (Fig. 1b). The Volcano plot 
of the top 100 genes displaying variations in their expression under fluid flow (150 
µl/min) compared to static (Fig 1c). Principal Component Analysis (PCA) of the 2944 
genes altered in dermal fibroblasts subjected to flow treatment (75 and 150 µl/min) 
shows that the first principal component containing the majority of variability in these 
genes clearly separates the samples exposed to static conditions from the samples 
exposed to fluid flow (75 and 150 たl/min) (Fig.1d). In order to further characterise the 
effects of fluid flow on fibroblasts the transcripts altered under flow (75 and 150 
µl/min) were examined for functional enrichment.  The KEGG pathways which were 
most highly changed under flow were the TGF- く signalling pathway and genes 
associated with clathrin and caveolin-mediated endocytosis. Figure 1e and 1f show 
the top 20 flow altered genes (p<0.01) functionally associated with endocytosis and 
the TGF-く pathway respectively.   
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Expression of g-SMA and collagen IA1 in dermal and oral fibroblasts is 
regulated by fluid flow. 
Given that genes associated with TGF-く signalling were altered under fluid flow (75 
and 150 µl/min), in order to further characterise the effects of fluid flow on fibroblasts 
we studied gene expression changes in myofibroblast associated markers such as g-
SMA (Fig. 2a, b) and Col IA1 (Fig. 2c, d) in dermal and oral fibroblasts, subjected to 
fluid flow. TGF-く1 stimulated cells treated in static cultures were used as positive 
controls for myofibroblast differentiation.  As previously reported (Hinsley et al., 
2012), we observed that TGF-く1 stimulation increased the levels of g-SMA and Col 
IA1 expression in dermal and oral fibroblasts in static conditions (Fig 2a,b). Fluid flow   
(150 µl/min) increased g-SMA gene expression by 1.9 fold in dermal and 3.9 fold in 
oral fibroblasts. Under the influence of fluid flow, Col IA1 gene expression increased 
by 3.4 fold in dermal and 1.5 fold in oral fibroblasts (Fig 2c, d). However, when TGF-
く1 stimulated fibroblasts were treated by fluid flow  (150 µl/min), g-SMA gene 
expression decreased by 1.1 fold in dermal and 3.4 fold in oral fibroblasts in 
comparison to those subjected to fluid flow treatment in the absence of TGF-く1 (Fig 
2a, b). Similarly, Col IA1 gene expression also decreased by 2.3 fold in dermal 
fibroblasts and 0.9 fold in oral fibroblasts stimulated by TGF-く1 under conditions of 
fluid flow compared to fibroblasts subjected to fluid flow only (Fig 2c, d).  
 
Dermal fibroblasts treated with fluid flow (150 µl/min) revealed intense staining of g-
SMA rich stress fibres whereas TGF-く1 supplemented and flow treated fibroblasts  
show very little g-SMA staining (Fig. 2e). Notably, these immunofluorescence studies 
on g-SMA expression are concordant with the results from gene expression analysis.  
However, when dermal fibroblast subjected to fluid flow (150 µl/min) for 24h. were 
allowed to rest in static conditions for 24h., the intensity of g-SMA staining decreased 
(Fig.2f).  
 
To study the functional role of TGF-く pathway in fluid flow induced fibroblast 
activation by treating dermal fibroblasts with fluid flow for 2h. TGF-く1 supplemented 
and flow treated fibroblasts were used as positive controls. Expression of 
phosphorylated SMAD3 was studied by immunofluorescence (Fig 2g). and by 
western blotting (Fig 2h). Immunofluorescence findings indicated that 
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phosphorylated SMAD3 protein translocated to the nucleus under fluid flow 
treatment as well as in TGF-く1 supplemented and flow treated fibroblasts. 
Concordantly, protein blot analysis of phosphorylated SMAD3 also showed increase 
in protein expression when fibroblasts were subjected to fluid flow.  
 
Cell associated and secreted TGF-く1 is enhanced under fluid flow. 
To assess effect of fluid flow on protein expression of TGF-く1, we extracted protein 
samples from both cellular lysate and conditioned medium of dermal fibroblasts 
subjected to flow (150µl/min) and static treatments. Secreted TGF-く1 in conditioned 
medium (Fig. 3a) and cell associated TGF-く1 (Fig. 3b) were elevated in comparison 
to static cultures with secreted TGF-く1 protein being significantly (p< 0.01) higher 
under flow. Further analysis by immunofluorescence detection of TGF-く1 revealed 
more intense staining in the perinuclear region in fibroblasts subjected to flow 
(Fig.3d) compared to those in static culture (Fig. 3c). 
 
Fluid flow enhances internalisation of caveolin-1A and nuclear translocation of 
the TGF-く receptor type 2.  
 
To explore whether the decrease in the activation response in TGF- く1-stimulated 
fibroblasts subjected to fluid flow was mediated by changes in endocytosis (Chen, 
2009), we studied the protein expression of caveolin-1A under flow, with and without 
cell permeabilization to detect both membrane bound and cytoplasmic protein 
expression. The results showed that fibroblasts in static culture conditions had 
intense staining for caveolin-1A on the cell surface (Fig. 4a) and low cytoplasmic 
expression (Fig. 4b). Cytoplasmic expression of caveolin 1A was increased in 
fibroblasts subjected to flow in both TGF- く1 stimulated and unstimulated conditions 
suggesting that under the influence of fluid flow, membrane bound caveolin 1A was 
internalised into the cell.  
 
Fibroblasts under flow were double immunolabelled to simultaneously detect early 
endosomal antigen-1, an endosomal marker, and transforming growth factor beta 
receptor 2 (TGF-くRII), the major physiological receptor for TGF- く1 (Heldin and 
Moustakas, 2016)(Fig. 5).  Little expression of EEA-1 and TGF-くRII was detected in 
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fibroblasts in basal static conditions. TGF-く1 stimulation in static culture resulted in 
enhanced expression of EEA-1 and fluid flow treatment triggered not only a similar 
increase in expression of EEA-1 but also promoted internalisation and nuclear 
translocation of TGF-くRII. The combination of TGF- く1 stimulation and fluid flow 
also induced nuclear translocation of TGF-くRII (Fig 5). 
 
Activin A expression is modulated by fluid flow. 
Our microarray analysis revealed activin A is one of the top 20 genes associated 
with the TGF-く pathway altered under fluid flow, suggesting that activin A may play a 
role in fluid flow-mediated fibroblast activation and buffering of responses to TGF-く1. 
In concordance with the microarray results, qPCR analysis revealed activin A 
transcript levels were increased by 2.5 fold in dermal fibroblasts subjected to fluid 
flow for 24 h (Fig. 6a). This was reduced by 0.8 fold in TGF-く1 stimulated fibroblasts 
subjected to fluid flow as compared to those under fluid flow only. Cell-associated 
(Fig. 6b) and secreted (Fig. 6c) and protein levels of activin A were measured by 
ELISA in cell lysates and conditioned medium after fluid flow stimulation of dermal 
fibroblasts in the presence and absence of TGF-く1. Results revealed that activin A 
was significantly (p< 0.01) increased in the conditioned culture medium and in cell 
extracts of fibroblasts subjected to flow. TGF-く1 stimulated fibroblasts in static and 
fluid flow conditions also showed elevated levels of cell-associated, but not secreted, 
activin A. 
 
To study whether activation of fibroblasts is regulated by activin A, dermal fibroblasts 
were treated with 1 ng/ml activin A and g-SMA protein was detected by 
immunofluorescence.  It was observed that activin A stimulation in static conditions 
increased expression of g-SMA (Fig. 7a) to a similar level observed in fibroblasts 
stimulated with TGF-く1.  When activin A stimulated fibroblasts were treated with 1 
ng/ml Follistatin-288, an activin A antagonist, protein expression of g-SMA 
decreased in comparison to cells treated with activin A alone. Image J based 
quantification of g-SMA staining (Fig. 7b and 7c)  revealed that treatment of TGF-く1-
stimulated dermal fibroblasts with follistatin-288 in static conditions also significantly 
decreased the protein expression of g- SMA (p< 0.0001). These results indicate that 
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To date, studies on fibroblast differentiation have largely been pursued in static 
conditions where cells are devoid of physical signals that resemble interstitial fluid 
flow in vivo. The highly dynamic environment in which fibroblasts reside and the 
effect of locally derived signals in this physiologically relevant dynamic environment 
have been somewhat neglected to date. We report here that pathways mediating 
fibroblast activation are regulated by physiologically relevant fluid flow conditions.  
 
We used the Quasi-vivo flow perfusion bioreactor to mimic shear stresses 
experienced by cells at a tissue level (A.Ahluwalia 2011, Vinci et al., 2010a). Under 
physiological conditions mesenchymal stem cells experience shear stresses in the 
order of 0.01 Pa to 0.1 Pa (Shieh and Swartz, 2011). From previous studies on the 
prototype of QV500 bioreactor used in our study, we have estimated that wall shear 
stress experienced by cells at a fluid flow velocity of 150 µl/min is 3.61x10-6  Pa 
(Mazzei et al., 2010). Flow rates (75 and 150 たl/min) used in our study are lower 
than those used in another study (500 µl/min) where effect of fluid flow on 
hepatocyte proliferation and growth was increased (Vinci et al., 2010a). From the 
body of literature on the Quasi vivo bioreactor, we concluded that it is likely that the 
flow rates used in our study are within the physiological range in which cells are 
exposed to in vivo.  
 
Our findings strengthen previous work where it was observed that interstitial fluid 
flow can activate fibroblasts when subjected to fluid flow at rate of 120µl/min (Ng et 
al., 2005). Here we show that even such low levels of shear stresses can induce 
changes in the global gene expression profile in both dermal and oral fibroblasts and 
activate fibroblasts of both dermal and oral origin. This included up-regulation of a 
number of members of the TGF-く family, a group of growth factors with key roles in 
regulating fibroblast phenotype. Microarray analysis of highly enriched genes sorted 
on the basis of statistical significance altered under fluid flow at both 75 & 150 µl/min 
showed up-regulation of TGF-く pathway modulators such as activin A, SMAD7, and 
down-regulation of pathway antagonists.  
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TGF-く1 stimulation increased expression of g-SMA in fibroblasts in static conditions, 
in keeping with our previous findings (Hinsley et al., 2012). Notably, fluid flow up-
regulated gene expression of g-SMA and Col IA1 in fibroblasts of both dermal and 
oral origin, despite there being evidence that there are phenotypic differences 
between fibroblasts from these two anatomical sites (Glim et al., 2014). However, 
TGF-く1 stimulation under fluid flow antagonised this activation response in cells of 
both origin. It is possible that the exogenous TGF-く1 in addition to increased 
endogenous levels with flow results in supra-physiological amounts which may inhibit 
this response. The fluid flow induced changes in fibroblast phenotype were shown to 
be reversible. 
 
In order to begin to examine the signalling mechanisms underlying these 
observations, SMAD3 phosphorylation was analysed. SMAD3 is a transcription 
factor, which remains localised to the cytoplasm in un-stimulated cells. Upon 
activation of TGF-く receptors, SMAD 3 is phosphorylated by TGFくR1, Alk4 and Alk5 
(Wrighton et al., 2009) and translocates to the nucleus. Nuclear localization of 
phosphorylated SMAD3 in dermal fibroblasts subjected to TGF-く1 stimulation and 
fluid flow suggests activation of the TGF-く pathway even within 2 h of flow treatment. 
It is likely that SMAD3 is phosphorylated transiently due to elevated levels of TGF-く1 
in the circulating medium even within 2 h flow and is dephosphorylated with time due 
to caveolin mediated membrane trafficking of TGF-く1 bound receptor complex into 
the nucleus. Whilst we cannot rule out the involvement of other signalling pathways, 
our microarray data reveal downregulation in gene expression of other R-SMADs 
from BMP signalling including SMAD1 and SMAD5. 
 
Studies have shown that fluid flow induces shear stresses in the proximal tubule 
(Raghavan and Weisz, 2015, Raghavan et al., 2014). Notably in our study, genes 
associated with endocytosis were modified by fluid flow in fibroblasts. In line with 
this, intense staining of caveolin 1A is observed in the cytoplasm of fibroblasts 
subjected to fluid flow in the presence and absence of TGF-く1 suggesting 
endocytosis contributes to this fluid flow induced mechano-response in fibroblasts . 
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In our efforts to identify the molecular mechanisms responsible for fibroblast 
differentiation under flow and the buffering of responses to TGF-く1, we observed 
that recombinant activin A (a gene upregulated by flow) can activate dermal 
fibroblasts and that this is inhibited by follistatin 288. Follistatin-288 attenuates TGF-
く1 mediated fibroblast differentiation by inhibiting not only activin A but also 
myostatin (Rodino-Klapac et al., 2009) a downstream regulator of the TGF-く 
pathway. Activin A was down-regulated in TGF-く1 stimulated fibroblasts subjected to 
fluid flow conditions, thus strengthening our hypothesis that fibroblast activation is 
mediated by activin A. Fumagalli et al. 2007 have shown that in tissue sections of 
hypertrophic scars, there were high numbers of g-SMA(+) myofibroblasts which co-
express activin A. Furthermore, treatment of fibroblasts with activin A induced Akt 
phosphorylation, promoted cell proliferation, and enhanced g-SMA and type I 
collagen expression. Follistatin reduced proliferation and suppressed activin-induced 
collagen expression suggesting that inhibition of activin A can potentially attenuate g-
SMA expression (Fumagalli et al., 2007). Although cell associated activin A was high 
in fibroblasts treated with TGF-く1 and flow, the protein was not secreted into the 
culture medium suggesting that secretion of activin A is inhibited by TGF-く1 
supplementation. It is possible that secreted activin A competitively binds to the 
TGF-く receptor type II (Aykul and Martinez-Hackert, 2016) and undergoes 
endocytosis mediated proteolytic degradation.  
 
Although our data confirms previous finding that interstitial fluid flow promotes 
fibroblast differentiation via TGF-く1 (Ng et al., 2005, Shieh et al., 2011) at a fluid flow 
rate of 120µl/min; we show here for the first time that the combined effect of fluid flow 
and TGF-く1 reverses this process. We provide evidence that this effect is associated 
with rapid nuclear localisation of TGF-くRII, which could result in disruption of TGF-く 
Receptor type II receptor-ligand complexes and degradation of receptors (Del Galdo 
et al., 2008). 
 
Our findings demonstrate that fibroblast responses to pro-differentiation signals, 
such as TGF-く1, are regulated by physiologically relevant physical forces and this 
factor must be considered when designing in vitro studies. Reversal of this activated 
phenotype in dermal fibroblasts upon withdrawal of fluid flow reveals that fibroblast 
activation through this mechanism is transient, and possibly indicates a mechanism 
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to respond to dynamic changes in the mechanical environment in vivo to allow 
homeostasis in connective tissue. We conclude that fluid flow acts as a homeostatic 
regulator of fibroblast phenotype, moderating fibroblast responses through the TGF-
く pathway. Our data provide the first direct evidence of fluid flow-mediated buffering 
of responses to chemical stimuli in fibroblasts.  
 
Materials and Methods 
Reagents and antibodies: All of the reagents used in this study were purchased from 
Sigma unless otherwise stated. The antibodies used are shown in Table 1.  
 
Cell Culture 
Normal oral fibroblasts (NOF-320) were derived from ethically approved waste 
tissues produced during oral surgical procedures undertaken at the Charles Clifford 
Dental Hospital, Sheffield, UK. Normal human dermal fibroblasts (NHDFC) were 
purchased from Promocell. Fibroblasts from both sources were cultured in DMEM 
supplemented with 10% (v/v) foetal calf serum (FCS) and 1% penicillin/streptomycin. 
Oral fibroblasts were used from a single donor at passage numbers between 3 and 
5and experiments were repeated three times. This study was approved by the 
University of Sheffield Ethics committee. (Ethics Committee approval Ref: 
07/H1309/105).  
Experimental design using the Quasi Vivo bioreactor 
The Quasi-Vivo bioreactor (Kirkstall Limited, UK) is composed of chambers of poly-
dimethyl-siloxane (PDMS), interconnected in a series (Fig. 1a). A pump circulated 
DMEM containing 0.5% FCS over fibroblast cultures in six chambers of the 
bioreactor. The cells were subjected to a flow rate of either 75 たL/ min or 150 たL/ min 
for 24 h. For experimentation, cells were seeded onto glass coverslips in 24-well 
plates and maintained at 37oC for 48h prior to transferring into flow chambers. 
Microarray analysis 
The effect of fluid flow was studied by subjecting dermal fibroblasts to varying fluid 
flow rates in the bioreactor for 24h. RNA was obtained from dermal fibroblasts 
exposed to 75µL/ min and 150µL/ min flow rate and linear amplification of the RNA 
was performed using the GeneChip® 3' IVT Express Kit (Affymetrix) according to the 
manufacturer暢s guidelines. Briefly, 200 ng RNA was reverse transcribed using an 
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oligo (dT) primers and then converted to double-stranded cDNA containing a T7 
polymerase promoter site. Linear amplification was driven by a T7 promoter for 16 
hours at 40oC and generated labelled antisense (aRNA) using biotinylated dUTPs. 
15µg of aRNA was fragmented in buffer containing Mg2+, at 94 0C for 30 minutes and 
analysed using an RNA 6000 Nano Chip on the 2100 Bioanalyzer (Agilent). 
Hybridisation was carried out using the GeneChip® Hybridization, Wash, and Stain 
Kit (Affymetrix). Briefly 12.5 µg of fragmented aRNA was added to the mastermix 
solution containing pre-labelled hybridization controls (bioB, bioC, bioD, and cre 
genes) and positive oligonucleotide B2 control (B2 oligo). After 16 hours 
hybridisation at 42oC with rotation at 60 rpm, the Affymetrix U133 Plus 2.0 
GeneChips were washed and stained in a GeneChip Fluidics Station 450 
(Affymetrix) according to the manufacturer暢s protocol. Scanning was carried out on a 
GeneChip Scanner 3000 7G (Affymetrix). The scanned image files (.CEL) were 
processed using the Expression Console software (Affymetrix) for quality control 
checks and to generate a robust multiarray average (RMA) normalised dataset of the 
signal intensity for each probeset. Differential gene expression was determined using 
the Qlucore Omics explorer (www.qlucore.com). Functional enrichment within 
differentially expressed genes was determined using the DAVID functional 
Annotation tool.   
Immunofluorescence staining  
g-SMA protein was detected in dermal fibroblasts subjected to a flow rate of 150µl/ 
min for 24 h. Cells were stimulated with 10ng/ml TGF-く1 (R&D systems) in both 
static and flow conditions. Cells were fixed in 100% methanol and permeabilised with 
4 mM sodium deoxycholate. Non-specific binding was blocked with 2.5% bovine 
serum albumin (BSA) in PBS followed by incubation with FITC conjugated anti-alpha 
smooth muscle actin (g-SMA) antibody in blocking buffer for one hour at 37ºC.  
Fibroblasts treated with fluid flow at a rate of 150µl/ min for 24 h. were left in static 
conditions for a further 24h and stained for g-SMA protein as above. 
Dermal fibroblasts subjected to a flow rate of 150 µl/ min for 2 h. were labelled for 
phospho- SMAD3, CAV-1A, EEA-1 and TGFくRII. Cells stimulated with 10 ng/ml 
TGF-く1 (R&D systems) were used in both static and flow conditions. Staining was 
performed by fixing cells in 4% paraformaldehyde, followed by cell permeabilization 
in 0.5% Triton-X 100. Non-specific protein binding was blocked with 1% BSA in PBS 
after which the cells were incubated with primary antibodies (Table 1). Cells were 
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then mounted in DAPI containing anti-fade reagent and viewed under a fluorescent 
microscope (Zeiss Axioplan2, Imaging with software proplus 7.0.1).  
TGF-く1 protein expression was detected in dermal fibroblasts subjected a flow rate 
of 150 µl/ min for 24 h., followed by immunofluorescence staining as described 
above. 
Quantitative PCR analysis  
Total RNA (100ng) was used as a template for cDNA synthesis using the High-
Capacity cDNA Reverse Transcription Kit (Applied Biosystems) according to the 
manufacturer暢s guidelines. The tubes were placed into a thermal cycler (DNA engine 
DYAD) at 25ºC for 10 min, 37ºC for 2 h, and 85 º C for 5 min and then held in 4ºC. 
0.5 µl of cDNA was added to qRT-PCR mastermix containing 1x SYBR green 
mixture (Applied Biosystems) with gene specific primers for g-SMA, Collagen IA1, 
Activin A and CD109 (Table 2).  Assays were performed in triplicate on a 7900HT 
Fast real time PCR machine (Applied Biosystems) SDS version 2.4. and RQ 
Manager Version 1.2.1(Applied Biosystems) was used to record the CT values as 
determined from the SDS manager software. The delta CT values with reference to 
endogenous controls (U6) were calculated manually. 
Immunoblotting  
Protein samples were extracted in RIPA lysis buffer containing protease and 
phosphatase inhibitors (Roche) from dermal fibroblasts subjected to fluid flow at 150 
µl/ min for 2 h. Cells stimulated with 10 ng/ml TGF-く1 (R&D systems) were used in 
both static and flow conditions. The protein concentration of each sample was 
determined using the BCA Protein Assay Kit (Thermo Fisher Scientific). 20 µg of 
total protein extract was reduced in Sample Reducing Agent (10x), loaded with LDS 
Sample loading buffer (4X) (Nupage) and electrophoresed in 12-15% (v/v) 
polyacrylamide gels along with EZ-RunTM Prestained Rec Protein Ladder (Fisher 
Bioreagents). Protein was transferred to a 0.2 µm nitrocellulose membrane (ProTran, 
GE Healthcare) using Trans-Blot® Turbo™ Transfer System (GE Healthcare). The 
membranes were blocked in 5% bovine serum albumin in 1X TBS containing 0.1% 
Tween-20 overnight at 4°C. Membranes were incubated with rabbit monoclonal anti-
Smad3 phospho S423 + S425 antibody for 1 h at room temperature.  Nitrocellulose 
membranes were washed three times in the TBS-Tween and then incubated with 
HRP conjugated anti-rabbit secondary antibody for 1 h at room temperature and 
washed three times in TBS-T. Protein bands were visualized using a 
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chemiluminescence detection kit (ECL Western Blotting Substrate, Pierce) and 
developed using XPosure film in an automatic processor. In order to determine 
loading efficiency, membranes were routinely stripped with Restore™ Western Blot 
Stripping Buffer (Thermo Scientific), blocked in TBS Tween for 1 h and reprobed with 
く-actin antibody for 1 h. Membranes were washed three times with TBS Tween and 
probed with HRP conjugated secondary antibody for 1 h. The membranes were 
visualised as described above.  
Enzyme linked immunosorbent assay (ELISA) 
Conditioned medium from cells were concentrated 5 times using Amicon Ultra-15 
Centrifugal Filter Units. Cellular lysate samples were obtained using RIPA lysis buffer 
containing protease inhibitors and the protein concentration was determined as 
above. Activin A and TGF-く1 concentration was determined using Activin A 
Quantikine ELISA Kit and TGFく1 Emax® ImmunoAssay System (Promega 
Corporation), respectively, according to manufacturer暢s instructions. Activin A and 
TGF- く1 concentration was estimated using the absorbance values of the standard 
curve and interpolating the test sample absorbance values using Graphpad Prism 7.  
Statistical analyses 
 Statistical significance of data was tested using one way ANOVA with multiple 
comparisons暢 test using Graph pad Prism. 
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List of Tables: 
Table 1: Antibodies used: 
 
Antigen Manufacturer Application 
 
Monoclonal Anti-Actin, g-Smooth Muscle - FITC 
(gSMA) antibody produced in mouse (clone 1A4, 
F3777) 
Sigma-Aldrich 1:100 for IF 
Rabbit polyclonal Anti-Caveolin-1 (ab 2910) Abcam 1:100 for IF 
Rabbit monoclonal Anti-Smad3 phospho S423 + 
S425 antibody (ab52903) 
Abcam 1:100 for IF, 
 1:1000 for WB 
Rabbit polyclonal Transforming Growth Factor Beta 
Receptor Type II (TGFくRII: L-21: SC-220) 
Santa Cruz 
Biotechnology 
1:50 for IF 
Mouse monoclonal Early Endosomal Antigen-1 
(610456) 
B.D Biosciences 1:100 for IF 
Anti-rabbit HRP-linked Antibody (7074) New England 
Biolabs 
1:3000 for WB 




1:200 for IF 




1:200 for IF 
Monoclonal Anti く Actin produced in mouse (A1978) Sigma 1:10,000 for 
WB 
Anti-Mouse HRP conjugated secondary Antibody 
(7076) 
Cell signalling  1:3000 for WB 
TGF Beta 1 Antibody (aa22-50) LS-C161825 Lifespan 
Biosciences 
1:50 for IF 
 
IF: Immunofluorescence; WB: Western Blot 
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g-SMA 5暢 GAAGAAGAGGACAGCACTG3暢 5暢TCCCATTCCCACCATCAA3暢 
collagen 
IA1 
5暢GTGGCCATCCAGCTGACC 3暢 5暢 AGTGGTAGGTGATGTTCTGGGAG 
3暢 
U6 5暢 CTCGCTTCGGCAGCACA 3暢 5ガ AACGCTTCACGAATTTGCGT 3暢 
activin A 5暢CCCCTTTGCCAACCTCAAA 3暢 5暢CATGGACATGGGTCTCAGCTT 3暢 
CD109 5暢AGCTGCTCAAGACAGCATCA3暢 5暢TTGGGGTCTGATGGAAGAGT3暢  
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Figure Legends: 
 
Figure 1:  Gene expression changes when dermal fibroblasts were subjected 
to fluid flow.  a)  Schematic diagram of Quasi Vivo bioreactor flow set up with six 
chambers connected with a pump circulating the medium over cells. Red arrows 
indicate direction of fluid flow. b) Heat map of 2944 transcripts that were differentially 
expressed under different flow rates (0, 75 and 150 たl/min) (t-test, p-value<0.05). c) 
Volcano plot of the top 100 differentially expressed transcripts by p-value. d) 
Factorisation by principal components was performed for fibroblast expression of the 
2944 transcripts which are altered under flow (75 and 150 たl/min).  The fibroblasts 
are plotted on the first three principal components; fibroblasts exposed to 75たL/min 
are plotted in yellow, fibroblasts exposed to 150 たl/min are plotted in cyan, and 
fibroblasts in static conditions are plotted in blue.   e) Top 20 genes associated with 
endocytosis altered under fluid flow (150 たl/min) (p<0.01) and f) Top 20 genes 
associated with TGF-く pathway altered under fluid flow (p<0.01). 
 
Figure 2: Expression of g-SMA, Collagen IA1 and phospho-SMAD3 under flow 
(150 たL/min).  Expression of g-SMA with fold change relative to endogenous control 
a) in Dermal (n=3) and b) Oral fibroblasts (n=3) (p < 0.05) subjected to flow. 
Expression of Collagen IA1 with fold change relative to endogenous control c) in 
Dermal (n=3) (p < 0.05) and d) Oral fibroblasts (n=3) (p < 0.05) subjected to flow. 
Error bars represent ±SEM.  e) Dermal Fibroblasts subjected to static conditions 
±TGF-く1 flow ±TGF-く1 for 24h (n=3). f) Dermal Fibroblasts subjected to static 
conditions ±TGF-く1 flow ±TGF-く1 and subjected to recovery in static conditions for 
24h (n=3), g) Dermal Fibroblasts subjected to flow for 2h. and stained with phospho-
SMAD3, h) Expression of phospho-SMAD3 protein relative to く-actin expression in 
dermal fibroblasts. All images were captured at 1000X magnification using the same 
exposure time.  
 
Figure 3: Changes in expression of caveolin 1a in dermal fibroblasts subjected 
to fluid flow (150µl/min) for 2h. a) Cell surface protein expression of caveolin-1A 
(green) in unpermeabilised dermal fibroblasts and b) cytoplasmic expression of 
caveolin-1A protein in permeabilised fibroblasts. 
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Figure 4: Expression of transforming growth factor く receptor type 2 and early 
endosomal antigen-1 in dermal fibroblasts subjected to flow (150 たL/min) for 2 
h.  Cells are stained with EEA-1 (green; 1), TGF-くRII (red; 2), and DAPI (blue; 3) 
and merged images (red, blue, green; 4) in fibroblasts treated a) in static conditions 
b) static conditions stimulated with TGF-く1 c) fluid flow and d) fluid flow stimulated 
with TGF-く1. All images were captured at 100X magnification.  
 
Figure 5: Expression of transforming growth factor く1 in dermal fibroblasts 
subjected to flow (150 たl/min) for 24h. a) Secreted TGF-く1 protein expression in 
dermal fibroblasts subjected to fluid flow at 150 µl/min (n=3) (* represents p < 0.05), 
b) Protein expression of cellular TGF-く1 in dermal fibroblasts subjected to fluid flow 
at 150 µl/min (n=2). Immunofluorescence detection of TGF-く1 in c) dermal 
fibroblasts treated in static conditions and d) dermal fibroblasts subjected to flow 
(n=3). 
 
Figure 6: Expression of activin A in dermal fibroblasts subjected to fluid flow 
(150 たl/min) treatment for 24h. a) Gene expression of activin A with fold change 
relative to endogenous control dermal fibroblasts subjected to flow (n=3) (* 
represents p < 0.05),  b) Protein expression of cell associated activin A (n=3) (*** 
represents p < 0.0001) and c) Protein expression of secreted activin A in dermal 
fibroblasts subjected to fluid flow (n=3) (*** represents p < 0.0001).   
 
Figure 7: Protein expression of g-SMA protein in dermal fibroblasts subjected 
to fluid flow (150 たl/min), follistatin-288, TGF-く1 and activin A treatment for 
24h. a) Expression of g-SMA protein in dermal fibroblasts subjected to fluid flow  
(150 たl/min) for 24h (n=3) Top panel: TGF-く1 (10 ng/ml), activin A (1 ng/ml), fluid flow 
(150 µl/min) and Bottom panel: Follistatin (1 ng/ml), TGF-く1  (10 ng/ml) treated with 
follistatin (1 ng/ml), activin A (1  ng/ml) treated with follistatin (1 ng/ml), Fluid flow 
(150 µl/min) treated with follistatin (1ng/ml). b) Image J based quantification of g-
SMA protein in dermal fibroblasts subjected to fluid flow  (150 たl/min) for 24h (n=3), 
treated with minimal medium, TGF-く1 (10 ng/ml), follistatin (1 ng/ml), activin A (1 
ng/ml), activin A (1 ng/ml) in combination with follistatin (1 ng/ml) and c) Image J 
based quantification of g-SMA protein in dermal fibroblasts in dermal fibroblasts 
treated with TGF-く1  (10ng/ml), TGF-く1  (10 ng/ml) in combination with follistatin (1 
 
This article is protected by copyright. All rights reserved
ng/ml), fluid flow (150 µl/min) in combination with follistatin (1 ng/ml). All images were 
captured at 1000 X magnification. Statistical bars represent p-value<0.0001, error 
bars represent ± SEM.  
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